US › Healthcare

InMode Ltd (INMD)

US · Healthcare · Medical Devices

$15.37+0.13%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$82.0M
Revenue YoY
+5.3%
Net profit
$11.6M
Profit YoY
-36.5%
EPS
$0.25
EPS estimate
$0.30
Net margin
14.1%

EPS came in at 0.25 against a street estimate of 0.30 — a miss of 16.7%.

Key statistics

Market cap
$870.3M
P/E
11.2
Forward P/E
11.2
P/B
1.32
Book value
$10.43
EPS (TTM)
$1.35
52-week high
$16.74
52-week low
$12.72
50-day MA
$14.37
200-day MA
$14.36
Beta
1.91

Analyst view

Analysts rate InMode Ltd a hold (2 buy, 5 hold, 0 sell out of 7) with an average price target of $15.33.

Shareholding

Insiders
13.15%
Institutions
58.60%

Largest institutional holders

FundStake
Doma Perpetual Capital Management LLC5.34%
Acadian Asset Management LLC4.51%
Renaissance Technologies Corp4.50%
BlackRock Inc3.92%
MENORA MIVTACHIM HOLDINGS LIMITED3.55%
Steel Partners Holdings LP3.12%
Morgan Stanley - Brokerage Accounts2.30%
Millennium Management LLC2.02%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for InMode Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.